**Warning:**	The NCBI web site requires JavaScript to function. 	more...

An official website of the United States government

**The .gov means it's official.**							Federal government websites often end in .gov or .mil. Before							sharing sensitive information, make sure you're on a federal							government site.						

**The site is secure.**							The **https://** ensures that you are connecting to the							official website and that any information you provide is encrypted							and transmitted securely.						

Log in

#### Account

                          - Dashboard
                          - Publications
                          - Account settings
                          - Log out

Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation

# Bookshelf

## 

                -  Browse Titles 
                -  Advanced 
                -  Help 
                -  Disclaimer 

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

                        - This publication is provided for historical reference only and the information may be out of date.

**This publication is provided for historical reference only and the information may be out of date.**

< PrevNext >

# Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in            Newborns and Infants

*AHCPR Clinical Practice Guidelines, No. 6*

Sickle Cell Disease Guideline Panel.

Agency for Health Care Policy and Research (AHCPR)1993 Apr

                            - Copyright and        Permissions

Bookshelf Copyright Notice

This clinical practice guideline sets forth a comprehensive program for identifying,            diagnosing, and treating newborns and infants with sickle cell disease and recommends            education and counseling strategies for their parents. Sickle cell disease comprises a            group of genetic disorders characterized by the production of hemoglobin S, anemia, and            acute and chronic tissue damage secondary to the blockage of blood flow by abnormally            shaped red cells. Sickle cell anemia is the most common form of the disease, and it            affects approximately 1 in 375 African-American infants. Although in the United States            sickle cell disease is most commonly found in persons of African ancestry, it also            affects other populations. The panel recommends screening of all newborns for sickle            cell disease, since targeting specific groups will miss some infected infants. Samples            of dried blood on filter paper or liquid blood samples should be used for            hemoglobinopathy screening. Hemoglobin electrophoresis, isoelectric focusing, and high            performance liquid chromatography are acceptable, reliable, and accurate testing            methods. Infants identified on initial screening must be retested to establish a            definitive diagnosis. Affected infants must be given twice-daily oral penicillin            beginning at 2 months of age to reduce pneumococcal infections. Parents must be taught            to recognize early signs and symptoms of specific complications, including fever,            splenic sequestration crisis, respiratory distress, and dehydration. Appropriate medical            followup includes regular visits to assess the infant's medical status and            administration of age-appropriate immunizations, including pneumococcal, conjugated            Haemophilus influenzae, and hepatitis B vaccines. Infants with sickle cell disease            require the same well-child care as infants without disease. Education and nondirective            genetic counseling should be offered to all parents of infants with sickle cell disease.            The guideline stresses the need for a comprehensive and fully integrated approach to            reduce morbidity and mortality from sickle cell disease. The guideline was developed by            a private-sector panel of health care experts and a consumer representative and is based            on the best science available, including hundreds of scientific sources and the            expertise and experience of panel members, consultants, and peer and pilot reviewers.         

## Contents

                          - Expand All
                          - Collapse All

                        - [Inside Front Cover]
                        - Guideline Development and Use
                        - Foreword
                        - Panel Members
                        - Acknowledgments
                        - Executive Summary
                        - Overview
                        - 1. Guideline: Population To Be Screened                           - Introduction
                          - Importance of Population Characteristics
                          - Difficulties in Assessing Characteristics
                          - Assumptions
                          - Methods
                          - Results
                          - Discussion
                          - Cost-Effectiveness of Screening
                          - Issues for Future Research
                        - 2. Guideline: Laboratory Screening for Sickle Cell Disease                           - Background
                          - Reporting
                          - Quality Assurance and Quality Control
                        - 3. Guideline: Medical Management of Newborns and Infants with Sickle Cell Disease                           - Entry Into Care
                          - Penicillin Prophylaxis
                          - Diagnosis and Management of Complications
                          - Health Maintenance
                        - 4. Recommendation: Educating and Counseling Parents of Newborns with Sickle Cell Disease    and Trait                           - Education
                          - Decision-Making Counseling
                          - Resources to Provide Educational and Decision-Making Counseling
                          - Qualifications for Sickle Cell Educators
                          - Counselor Qualifications
                          - Conclusion
                        - Acronyms
                        - Glossary
                        - Biosketches: Sickle Cell Disease Guideline Panel Members
                        -     Contributors [1]
                        -     Attachments
                        - References

                          - Expand All
                          - Collapse All

#### Suggested citation:

Sickle Cell Disease Guideline Panel. Sickle Cell               Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants.               Clinical Practice Guideline No. 6. AHCPR Pub. No. 93 0562. Rockville, MD: Agency for               Health Care Policy and Research, Public Health Service, U.S. Department of Health and               Human Services. April 1993.

Copyright Notice

Bookshelf ID: NBK52254

< PrevNext >

Share

### Views

                    - PubReader
                    - Print View
                    - Cite this Page Sickle Cell Disease Guideline Panel. Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants. Rockville (MD): Agency for Health Care Policy and Research (AHCPR); 1993 Apr. (AHCPR Clinical Practice Guidelines, No. 6.)

### Other titles in these collections

                    - AHCPR               Supported Guides and Guidelines
                    - Health Services/Technology Assessment Text (HSTAT)

### Recent Activity

ClearTurn OffTurn On
                      - Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborn... Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants 
                      - Strategies To Support Quality-based Purchasing Strategies To Support Quality-based Purchasing 
                      - Value of the Periodic Health Evaluation Value of the Periodic Health Evaluation 
                      - Effects of Soy on Health Outcomes Effects of Soy on Health Outcomes 
                      - Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstruc... Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD) 

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on
See more...

TwitterFacebookLinkedInGitHubNCBI Insights Blog

Connect with NLM
                      - Twitter
                      - Facebook
                      - Youtube

National Library of Medicine8600 Rockville Pike							Bethesda, MD 20894

Web PoliciesFOIAHHS Vulnerability Disclosure

HelpAccessibilityCareers

-  NLM 
-  NIH 
-  HHS 
-  USA.gov